Legal Representation
Attorney
George Lyons, III
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 18, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Aug 18, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 21, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 21, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| May 21, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Apr 17, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 17, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 17, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 20, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jan 20, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Oct 18, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 18, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 18, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 16, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 11, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 11, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 4, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 4, 2024 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Apr 3, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 3, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medical clinics namely providing and evaluating oncology rheumatology, neurology, and autoimmune disease treatment and vaccines, namely neoantigen vaccines and chimeric antigen receptor (CAR) T cell therapy; healthcare services for treating oncology, rheumatology, neurology, and autoimmune disease treatment and vaccines; consulting services in the field of medical care
Additional Information
Design Mark
The mark consists of the wording "IMMUNOBRIDGE" in dark blue with a DNA helix inspired graphic transitioning from green to blue, against a white background.
Color Claim
The color(s) green, teal, light blue, dark blue, and white is/are claimed as a feature of the mark.
Classification
International Classes
044